Bioqual, Inc. (BIOQ)

OTCMKTS · Delayed Price · Currency is USD
37.51
-0.19 (-0.50%)
At close: Feb 6, 2026
-37.48%
Market Cap 33.55M
Revenue (ttm) 46.54M
Net Income (ttm) 453.26K
Shares Out 894.42K
EPS (ttm) 0.51
PE Ratio 74.02
Forward PE n/a
Dividend 0.50 (1.33%)
Ex-Dividend Date Oct 7, 2024
Volume 233
Average Volume 750
Open 37.51
Previous Close 37.70
Day's Range 37.51 - 37.51
52-Week Range 33.00 - 57.50
Beta -0.07
RSI 21.71
Earnings Date Apr 16, 2026

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and ... [Read more]

Sector Healthcare
Founded 1981
Employees 113
Stock Exchange OTCMKTS
Ticker Symbol BIOQ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.